Bea Wisman is a mol. biologist and obtained her PhD at Depts. Med Oncology and Gyn Oncology, University Medical Center Groningen (prof dr EGE de Vries). She has a leading role worldwide in the evaluation of (biological) tumor markers (e.g. methylation) in gynecologic cancers with emphasis on cervical, for the early detection of cervical neoplasia, and ovarian cancer. She is member of the scientific advisory board of CC Diagnostics (the Netherlands) and Novosanis (Belgium).